By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Akriveia Therapeutics 



Thousand Oaks  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Akriveia Therapeutics is discovering and developing the next generation of cancer immunotherapies. Akriveia’s new agents offer the promise of a safer and more efficacious approach to harness a patient’s own immune system to attack cancer.

About our name: “Akriveia” is a Greek word meaning “Precision” or “Accuracy” and reflects our mission to develop best-in-class immunotherapeutics through the precise targeting of our therapeutics to tumors.


YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Simon Tomlinson

CSO: C. Glenn Begley

Co-Founder and Member of Scientific Advisory Board: Uli Rodeck

Co-Founder and Member of Scientific Advisory Board: John C. Williams

Vice President, Discovery and Preclinical Development: Margaret Karow

JOBS:

Please click here for Akriveia's job opportunities.


Key Statistics


Email: nfo@akriveiatx.com
Ownership: Private

Web Site: Akriveia Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->